Page last updated: 2024-11-05

vesnarinone and Cardiomyopathy, Congestive

vesnarinone has been researched along with Cardiomyopathy, Congestive in 9 studies

Research Excerpts

ExcerptRelevanceReference
"Myocarditis is thought to be caused by various viruses, and accumulating evidence links viral myocarditis with the eventual development of dilated cardiomyopathy."2.39Cytokines in myocarditis and cardiomyopathies. ( Matsumori, A, 1996)
"Xamoterol was highly effective in patients with atrial fibrillation who not only had excessive tachycardia during exercise but marked bradycardia at night."1.28[How to select newly-developed oral inotropic agents: an evaluation based on their effects on heart rate and arrhythmias]. ( Fukuda, K; Handa, S; Kawamura, Y; Nakamura, Y; Ogawa, S, 1990)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19902 (22.22)18.7374
1990's7 (77.78)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertolet, BD1
White, BG1
Pepine, CJ1
O'Connell, JB1
Moore, CK1
Waterer, HC1
Matsumori, A2
Sasayama, S2
Kurabayashi, M1
Yamaoki, K1
Yazaki, Y1
Feldman, AM2
Baughman, KL2
Lee, WK1
Gottlieb, SH1
Weiss, JL1
Becker, LC2
Strobeck, JE1
Fukuda, K1
Handa, S1
Ogawa, S1
Nakamura, Y1
Kawamura, Y1
Llewellyn, MP1
Inoue, M1
Asanoi, H1
Kodama, K1
Hori, M1
Sakurai, T1
Kawai, C1

Reviews

4 reviews available for vesnarinone and Cardiomyopathy, Congestive

ArticleYear
Treatment of end stage dilated cardiomyopathy.
    British heart journal, 1994, Volume: 72, Issue:6 Suppl

    Topics: Adrenergic beta-Antagonists; Cardiomyopathy, Dilated; Cardiotonic Agents; Heart Transplantation; Hum

1994
Immunomodulating agents for the management of heart failure with myocarditis and cardiomyopathy--lessons from animal experiments.
    European heart journal, 1995, Volume: 16 Suppl O

    Topics: Adjuvants, Immunologic; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; B

1995
Cytokines in myocarditis and cardiomyopathies.
    Current opinion in cardiology, 1996, Volume: 11, Issue:3

    Topics: Animals; Cardiomyopathy, Dilated; Cardiotonic Agents; Cytokines; Heart Injuries; Hepatitis C; Humans

1996
[Dilated cardiomyopathy in children].
    Ryoikibetsu shokogun shirizu, 1996, Issue:14

    Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Cardiotonic Agents; Child; Child,

1996

Trials

2 trials available for vesnarinone and Cardiomyopathy, Congestive

ArticleYear
Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy.
    The American journal of cardiology, 1991, Nov-01, Volume: 68, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Cardioton

1991
Evaluation of a new inotropic agent, OPC-8212, in patients with dilated cardiomyopathy and heart failure.
    American heart journal, 1988, Volume: 116, Issue:3

    Topics: Adult; Cardiomyopathy, Dilated; Cardiotonic Agents; Clinical Trials as Topic; Exercise Test; Female;

1988

Other Studies

3 other studies available for vesnarinone and Cardiomyopathy, Congestive

ArticleYear
Neutropenia occurring during treatment with vesnarinone (OPC-8212).
    The American journal of cardiology, 1994, Nov-01, Volume: 74, Issue:9

    Topics: Cardiomyopathy, Dilated; Cardiotonic Agents; Clinical Trials as Topic; Europe; Female; Granulocyte C

1994
[How to select newly-developed oral inotropic agents: an evaluation based on their effects on heart rate and arrhythmias].
    Journal of cardiology, 1990, Volume: 20, Issue:3

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Atrial Fibrillation; Car

1990
Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failure.
    Heart and vessels, 1986, Volume: 2, Issue:1

    Topics: Administration, Oral; Adult; Aged; Cardiac Output; Cardiomyopathy, Dilated; Cardiotonic Agents; Coro

1986